VJHemOnc is committed to improving our service to you

ASCO 2019 | CAR-T for ALL: bridging options and choices

VJHemOnc is committed to improving our service to you

Karlo Perica

Karlo Perica, MD, PhD, of the Memorial Sloan Kettering Cancer Center, New York, NY, explains the options clinicians have when choosing bridging options for acute lymphoblastic leukemia (ALL) patients undergoing CAR T-cell therapy, and how decisions are made. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter